About the Company
We do not have any company description for Scilex Holding Co at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on Scilex Holding Co
Scilex Holding Company Announces Launching of Co-Pay Programs for Both ...
Scilex Holding Company is an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain.
Scilex Shares Rise After SEC Clears S-4 for Semnur Merger
Scilex Holding Company (NASDAQ:SCLX) saw its stock climb 6.9% after the U.S. Securities and Exchange Commission declared effective the registration statement for its planned merger with Semnur ...
Scilex Holding Company Provides Certain Preliminary Unaudited Financial ...
Scilex Holding Company is an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain.
Scilex Holding Company Announces 1-for-35 Reverse Stock Split
Scilex Holding Company is an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic ...
Scilex Holding Company Announces Deferral of Preferred Stock ... - Nasdaq
Scilex Holding Company announced that its Board of Directors has decided to defer the record date for a previously announced preferred stock dividend, originally set for May 2, 2025, to a later ...
Scilex Holding Company Chief Executive Officer and President ... - KRON4
Scilex Holding Company is an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain.
Scilex Holding Company Announces Early Repayment of $13.2 ... - Nasdaq
Scilex Holding Company, based in Palo Alto, California, has announced a voluntary early installment payment of $13.2 million towards its senior secured promissory note issued to Oramed ...
Scilex Holding Company Presented Post-Hoc Analysis of the C.L.E.A.R. Trial on Clinical Meaningfulness of Safety and Efficacy of SP-102 for the Treatment of Lumbosacral ...
Detailed price information for Scilex Holding Company WT (SCLXW-Q) from The Globe and Mail including charting and trades.
Scilex Holding Company Announces Extension of the Maturity Date of its ...
Scilex Holding Company is an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic ...
Scilex Holding Company Announces Publication of Its Inaugural ...
Scilex Holding Company is an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain.
Scilex Holding Company Announces Signing of a $50 Million Registered ...
SEMDEXAâ„¢ (SP-102) is a trademark owned by Semnur Pharmaceuticals, Inc., a wholly-owned subsidiary of Scilex Holding Company. A proprietary name review by the FDA is planned.
Similar Companies
Loading the latest forecasts...